片頭痛の治療のためのフレマンズマブ
Dimos Mitsikostas1, Srdjan Ljubisavljevic2
1First Neurology Department, Aeginition Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Pain management
|September 1, 2025
まとめ
フレマネズマブはCGRP阻害剤であり,以前治療が失敗した患者や併発性うつ病でも効果的に偏頭痛を予防し,よく耐える. 偏頭痛予防の第一線として推奨されています.
科学分野:
- 神経学
- 薬理学について
- 免疫学
背景:
- 片頭痛は衰弱する神経疾患です.
- 現在の治療法には 効能と耐性の限界があります
- カルシトニン遺伝子関連ペプチド (CGRP) のシグナル伝達は,片頭痛の病理学において極めて重要です.
研究 の 目的:
- 片頭痛予防のフレメネズマブの有効性,耐受性,および安全性の検討
- 特定の患者集団におけるフレメネズマブの有効性を評価する.
- フレメネズマブの最新データと承認について
主な方法:
- フレメネズマブに関するPubMedの体系的な文献検索
- 作用のメカニズム,有効性,耐受性,安全性を強調する.
- 臨床試験と現実世界の研究データの分析
主要な成果:
- フレメネズマブのエピソード性および慢性的な片頭痛予防の有効性は,クラスIの証拠によって支持されています.
- プラセボと比較して毎月の片頭痛の日数を減らし,実際の環境ではより大きな効果を発揮します.
- 薬物の過剰使用,治療の失敗,併発性うつ病の患者に有意義な効果を示しています.
- 一般的な副作用は,注射部位での軽度の反応です.
結論:
- フレマネズマブは,従来の片頭痛治療と比較して,好ましい効果・有害性プロファイルを提供します.
- 青少年を含む様々な患者群で有効であり,よく耐える.
- フレマネズマブは,偏頭痛の予防に最適な第一線治療法と考えられています.
関連する概念動画
01:23Antidepressant Drugs: MAOIs and Other Agents
340
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
340
01:20Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
238
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
238
01:14Antiepileptic Drugs: Glutamate Antagonists
511
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
511